EMILY HAIRFIELD: Open Payments
NPI 1518404573 · BLACKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 55 payments from 13 companies in 2025. Trend: 2023 $938 · 2024 $751 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $214 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $212 |
| Regeneron Healthcare Solutions, Inc. | 6 | $181 |
| ABBVIE INC. | 9 | $151 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $83 |
| UCB, Inc. | 3 | $79 |
| GENZYME CORPORATION | 2 | $65 |
| Incyte Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Organogenesis Inc. | 2 | $43 |
Products named: TREMFYA, DUPIXENT, ILUMYA, SKYRIZI, Bimzelx, RINVOQ, LIBTAYO, OPZELURA.
Industry payments across VA — which companies pay providers there.
